Gout models of care: The next step is to facilitate implementation

Philip C Robinson^{1

2}

Affiliations

¹ University of Queensland Faculty of Medicine, Brisbane, Qld, Australia.
² Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Brisbane, Qld, Australia.

Editorial

Philip C Robinson. Int J Rheum Dis. 2020 Sep.

. 2020 Sep;23(9):1115-1116.

doi: 10.1111/1756-185X.13900.

Philip C Robinson^{1

2}

¹ University of Queensland Faculty of Medicine, Brisbane, Qld, Australia.
² Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Brisbane, Qld, Australia.

No abstract available

References

1. Gill I, Dalbeth N, ‘Ofanoa M, Felicity G‐S. Interventions to improve uptake of urate‐lowering therapy in gout patients: systematic review. Br J Gen Pract Open, 2020. https://doi.org/10.3399/bjgpopen20X101051.
1. Doherty M, Jenkins W, Richardson H, et al. Efficacy and cost‐effectiveness of nurse‐led care involving education and engagement of patients and a treat‐to‐target urate‐lowering strategy versus usual care for gout: a randomised controlled trial. Lancet. 2018;392:1403‐1412.
1. Robinson PC, Taylor WJ, Dalbeth N. An observational study of gout prevalence and quality of care in a National Australian General Practice Population. J Rheumatol. 2015;42(9):1702‐1707.
1. Singh JA, Hodges JS, Asch SM. Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis. 2009;68(8):1265‐1270.
1. Bavanendrakumar M, Robinson PC. Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia. Intern Med J. 2020;50(3):337‐341.